Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 5 studies | 28% ± 10% | |
type I pneumocyte | 5 studies | 21% ± 4% | |
type II pneumocyte | 5 studies | 22% ± 5% | |
glutamatergic neuron | 4 studies | 60% ± 27% | |
GABAergic neuron | 4 studies | 58% ± 25% | |
club cell | 4 studies | 28% ± 6% | |
endothelial cell | 3 studies | 22% ± 2% | |
epithelial cell | 3 studies | 25% ± 7% | |
retinal rod cell | 3 studies | 23% ± 6% | |
T follicular helper cell | 3 studies | 18% ± 1% | |
hepatocyte | 3 studies | 28% ± 7% | |
astrocyte | 3 studies | 40% ± 16% | |
oligodendrocyte precursor cell | 3 studies | 34% ± 14% | |
respiratory goblet cell | 3 studies | 36% ± 10% | |
basal cell | 3 studies | 24% ± 5% | |
interneuron | 3 studies | 51% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 991.50 | 328 / 328 | 99% | 18.16 | 177 / 178 |
thymus | 100% | 437.42 | 651 / 653 | 100% | 27.68 | 603 / 605 |
prostate | 96% | 708.50 | 234 / 245 | 99% | 33.11 | 498 / 502 |
kidney | 100% | 696.96 | 89 / 89 | 93% | 13.50 | 842 / 901 |
lung | 93% | 223.50 | 537 / 578 | 96% | 17.67 | 1110 / 1155 |
liver | 100% | 676.96 | 226 / 226 | 83% | 12.22 | 336 / 406 |
stomach | 75% | 282.28 | 268 / 359 | 91% | 14.18 | 259 / 286 |
breast | 64% | 309.66 | 294 / 459 | 97% | 29.95 | 1086 / 1118 |
intestine | 48% | 131.74 | 467 / 966 | 97% | 16.56 | 510 / 527 |
bladder | 52% | 138.52 | 11 / 21 | 92% | 15.12 | 464 / 504 |
adrenal gland | 63% | 90.22 | 163 / 258 | 76% | 10.02 | 175 / 230 |
esophagus | 48% | 190.88 | 687 / 1445 | 86% | 10.10 | 157 / 183 |
ovary | 13% | 12.69 | 24 / 180 | 95% | 14.64 | 407 / 430 |
uterus | 17% | 33.88 | 29 / 170 | 84% | 18.09 | 385 / 459 |
tonsil | 0% | 0 | 0 / 0 | 91% | 18.22 | 41 / 45 |
skin | 72% | 701.68 | 1305 / 1809 | 4% | 0.32 | 20 / 472 |
brain | 69% | 142.78 | 1822 / 2642 | 2% | 0.14 | 17 / 705 |
lymph node | 0% | 0 | 0 / 0 | 69% | 9.85 | 20 / 29 |
spleen | 63% | 75.33 | 151 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 34% | 61.73 | 318 / 929 | 0% | 0 | 0 / 0 |
adipose | 30% | 42.71 | 356 / 1204 | 0% | 0 | 0 / 0 |
heart | 3% | 2.81 | 24 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 2.92 | 25 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
muscle | 0% | 0.36 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0005811 | Cellular component | lipid droplet |
GO_0016020 | Cellular component | membrane |
GO_0017064 | Molecular function | fatty acid amide hydrolase activity |
Gene name | FAAH2 |
Protein name | Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2) |
Synonyms | AMDD |
Description | FUNCTION: Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules . Hydrolyzes monounsaturated substrate anandamide preferentially as compared to polyunsaturated substrates. . |
Accessions | ENST00000374900.5 Q6GMR7 |